HyTdb

8E

HyT-026 | Adamantane | Published 2023.06.07

Basic Information

GANT61D
Linker
Adamantane
POIGLI1 — Zinc finger protein GLI1(GLI1)
Degradation PathwayUbiquitin-Proteasome Pathway
Published2023.06.07

Remarks

Chemical Identifiers

SMILESCN(C)C1=CC=CC=C1CNCCCNCC2=CC=C(OCCOCCNC(CC3(C4)C[C@@H](C5)C[C@H]4C[C@@H]5C3)=O)C=C2
Molecular Formula5.1402
InChIInChI=1S/C35H52N4O3/c1-39(2)33-7-4-3-6-31(33)26-37-13-5-12-36-25-27-8-10-32(11-9-27)42-17-16-41-15-14-38-34(40)24-35-21-28-18-29(22-35)20-30(19-28)23-35/h3-4,6-11,28-30,36-37H,5,12-26H2,1-2H3,(H,38,40)/t28-,29+,30-,35?
InChI KeyHCFZMEOMSJNFFV-LYCRWBIHSA-N
IUPAC NameNA
PubChem CIDNA

Basic Properties

TPSAComputing…
RingsComputing…
FSP3Computing…
Heavy Atom CountComputing…

Lipinski RO5

RO5 ViolationComputing…
MWComputing…
ClogPComputing…
HBDComputing…
HBAComputing…
RBComputing…

Hydrophobic Tag Properties

Tag Structure
Tag TypeAdamantane
Tag SMILESC1(CC2C3)CC(C2)CC3C1
Tag ClogP5.022
HydrophobicityHigh(ClopP>5)

Mechanism of Action

POI (Protein of Interest)

POI NameZinc finger protein GLI1(GLI1)
GeneGLI1
UniProt IDP08151

Amino Acid Sequence

MFNSMTPPPISSYGEPCCLRPLPSQGAPSVGTEGLSGPPFCHQANLMSGPHSYGPARETNSCTEGPLFSSPRSAVKLTKKRALSISPLSDASLDLQTVIRTSPSSLVAFINSRCTSPGGSYGHLSIGTMSPSLGFPAQMNHQKGPSPSFGVQPCGPHDSARGGMIPHPQSRGPFPTCQLKSELDMLVGKCREEPLEGDMSSPNSTGIQDPLLGMLDGREDLEREEKREPESVYETDCRWDGCSQEFDSQEQLVHHINSEHIHGERKEFVCHWGGCSRELRPFKAQYMLVVHMRRHTGEKPHKCTFEGCRKSYSRLENLKTHLRSHTGEKPYMCEHEGCSKAFSNASDRAKHQNRTHSNEKPYVCKLPGCTKRYTDPSSLRKHVKTVHGPDAHVTKRHRGDGPLPRAPSISTVEPKREREGGPIREESRLTVPEGAMKPQPSPGAQSSCSSDHSPAGSAANTDSGVEMTGNAGGSTEDLSSLDEGPCIAGTGLSTLRRLENLRLDQLHQLRPIGTRGLKLPSLSHTGTTVSRRVGPPVSLERRSSSSSSISSAYTVSRRSSLASPFPPGSPPENGASSLPGLMPAQHYLLRARYASARGGGTSPTAASSLDRIGGLPMPPWRSRAEYPGYNPNAGVTRRASDPAQAADRPAPARVQRFKSLGCVHTPPTVAGGGQNFDPYLPTSVYSPQPPSITENAAMDARGLQEEPEVGTSMVGSGLNPYMDFPPTDTLGYGGPEGAAAEPYGARGPGSLPLGPGPPTNYGPNPCPQQASYPDPTQETWGEFPSHSGLYPGPKALGGTYSQCPRLEHYGQVQVKPEQGCPVGSDSTGLAPCLNAHPSEGPPHPQPLFSHYPQPSPPQYLQSGPYTQPPPDYLPSEPRPCLDFDSPTHSTGQLKAQLVCNYVQSQQELLWEGGGREDAPAQEPSYQSPKFLGGSQVSPSRAKAPVNTYGPGFGPNLPNHKSGSYPTPSPCHENFVVGANRASHRAAAPPRLLPPLPTCYGPLKVGGTNPSCGHPEVGRLGGGPALYPPPEGQVCNPLDSLDLDNTQLDFVAILDEPQGLSPPPSHDQRGSSGHTPPPSGPPNMAVGNMSVLLRSLPGETEFLNSSA

3D Structure (/structures/AF-P08151-F1-model_v6.cif)

Loading /structures/AF-P08151-F1-model_v6.cif …

Function

Acts as a transcriptional activator. Binds to the DNA consensus sequence 5'-GACCACCCA-3'. Regulates the transcription of specific genes during normal development. Plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Mediates SHH signaling. Plays a role in cell proliferation and differentiation via its role in SHH signaling.

Degradation Pathway

NameUbiquitin-Proteasome Pathway
Assay MethodWB,IP

Mechanism

The ubiquitin-proteasome pathway (UPP) constitutes the principal pathway for protein degradation in eukaryotic cells, mediating the breakdown of target proteins through ubiquitin tagging and subsequent proteasomal degradation. In an ATP-dependent manner, the ubiquitin-activating enzyme (E1) activates ubiquitin (Ub) and conjugates it to a ubiquitin-conjugating enzyme (E2). E3 ligase subsequently catalyzes the transfer of Ub to the target protein, leading to the formation of a polyubiquitin chain that completes the ubiquitination mark. The 19S regulatory particle of the 26S proteasome recognizes this ubiquitination signal and, after deubiquitination, mediates the ATP-dependent delivery of the substrate into the 20S proteasome for degradation.

Description

Having identified 8e as an effective Gli1 degrader, we continued to investigate its protein degradation mechanism. Theoretically, the hydrophobic tag-mediated degradation does not require the participation of E3 ligase [38], therefore, two proteasome inhibitors, MG132, a 26S proteasome inhibitor, and PS341 (Bortezomib), a 20S proteasome inhibitor, were employed to explore the Gli1 degradation mechanism of 8e. As shown in Fig. 4C–E, the two proteasome inhibitors almost completely reversed the Gli1 degradation effect, suggesting the proteasome-dependent degradation by 8e

Activity Data

TypeDC50
Value5.4 μM
POI NameGli1
Cell Line:HT29
Cell Line IDCVCL_A8EZ
Assay MethodWB
Reference10.1016/j.bioorg.2023.106649

Description

Subsequently, the HyT Gli1 degrader 8e, which exerted potent inhibitory effect on the proliferation of HT29 cells, was applied for western blotting analysis in HT29 cells to examine the Gli1 protein degradation effects. As shown in Fig. 4A, the hydrophobic tagging molecule 8e can concentration-dependently downregulate the protein levels of Gli1 at 24 h incubation, resulting in a DC50 value of 5.4 μM (Fig. S-3). In addition, 8e also rapidly degraded the Gli1 protein in a time-dependent manner Fig. 4B).

TypeIC50
Value0.462 μM
POI NameGli1
Cell LineHT29
Cell Line IDCVCL_A8EZ
Assay MethodCCK-8 assay
Reference10.1016/j.bioorg.2023.106649

Description

As shown in Table 1, all the bifunctional molecules exhibited improved cell proliferation inhibitory activities compared to Gli1 inhibitor 4 or 5. Among them, the best HyT degrader 8e (IC50 =0.462 μM).

Disease Information

DiseaseICD-11Source
Postaxial Polydactyly Type B:LB78.2Gene-Disease Association
Ellis-Van Creveld SyndromeLD27.0YGene-Disease Association
Aneurysmal Bone CystsFB80.6Gene-Disease Association
Ewing SarcomaXH8KJ8Gene-Disease Association
HoloprosencephalyLA05.2Gene-Disease Association
Bone DiseaseFC0ZGene-Disease Association